RxDoctor Payments Data

Rebecca Robbins, PA

Physician Assistant · Dallastown, PANPI 1083786263

Payments from drug & device makers

$7,428in general payments, 2019–2025

Across 445 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$840
  • Novo Nordisk$820
  • AbbVie$770
  • Pfizer$664
  • AstraZeneca$653
  • Lilly USA, LLC$568
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$7,26498%
  • Education$1642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,428 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$66,627
Medicare patients
210
Services billed
2,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide21$22,473
OzempicSemaglutide15$21,922
EliquisApixaban22$18,614
FarxigaDapagliflozin Propanediol21$18,613
Breo ElliptaFluticasone/Vilanterol15$5,850
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$2,274
Valsartan48$1,727
Atorvastatin Calcium174$1,553
SynthroidLevothyroxine Sodium12$812
Diclofenac Sodium17$773
Lisinopril112$721
Pravastatin Sodium26$656
Metoprolol Succinate58$606
Escitalopram Oxalate41$548
Albuterol Sulfate HfaAlbuterol Sulfate27$516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$568$22,47321 claims
Novo NordiskOzempic$820$21,92215 claims
PfizerEliquis$664$18,61422 claims
AstraZenecaFarxiga$653$18,61321 claims
GSKBreo Ellipta$840$5,85015 claims
AbbVieSynthroid$770$81212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Dallastown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →